New insights into migraine pathophysiology

Current Opinion in Neurology

Volumn 19, Issue 3, 2006, Pages 294-298

  Sanchez Del Rio, Margarita ^a   Reuter, Uwe ^b   Moskowitz, Michael A ^c  

^a HOSPITAL RUBER INTERNACIONAL   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cortical spreading depression; Genetics; Migraine aura; Prevention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; FLUNARIZINE; GLUTAMIC ACID; HALOTHANE; METHYSERGIDE; METOPROLOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; POTASSIUM; PROPRANOLOL; SEROTONIN 2 RECEPTOR; SODIUM; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AMINO ACID TRANSPORT; BRAIN BLOOD VESSEL; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN REGION; CEREBELLUM; CHROMOSOME 19P; CHROMOSOME 1Q; CLINICAL RESEARCH; DIAGNOSTIC IMAGING; ELECTROSTIMULATION; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; ION TRANSPORT; MIGRAINE; NERVE FUNCTION; NEUROBIOLOGY; PATHOPHYSIOLOGY; POINT MUTATION; POTASSIUM TRANSPORT; REVIEW; SODIUM TRANSPORT; SPREADING CORTICAL DEPRESSION; SYNAPTIC MEMBRANE; WAVEFORM;

ANIMALS; CORTICAL SPREADING DEPRESSION; HUMANS; MIGRAINE DISORDERS; POINT MUTATION; POLYMORPHISM, GENETIC; SPREADING CORTICAL DEPRESSION;

EID: 33744488514     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000227041.23694.5c     Document Type: Review

References (36)

1. Bolay H, Moskowitz MA. The emerging importance of cortical spreading depression in migraine headache. Rev Neurol (Paris) 2005; 161:655-657.
2. Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002; 8:136-142.
3. Lang E, Kaltenhauser M, Neundorfer B, Seidler S. Hyperexcitability of the primary somatosensory cortex in migraine - a magnetoencephalographic study. Brain 2004; 127:2459-2469.
4. Ambrosini A, de Noordhout AM, Sandor PS, Schoenen J. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia 2003; 23 (Suppl. 1):13-31.
5. 2+ channel gene CACNL1A4. Cell 1996; 87:543-552.
6. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003; 4:386-398.
7. Van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004; 41:701-710.
8. Tottene A, Fellin T, Pagnutti S, et al. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 2002; 99:13284-13289.
9. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192-196.
10. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005; 366:371-377. Identification in three families with FHM of a novel mutation in the SCN1A gene on chromosome 2 that encodes voltage-gated sodium channels.
11. Mantegazza M, Gambardella A, Rusconi R, et al. Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci USA 2005; 102:18177-18182.
12. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 2004; 55:276-280.
13. McCarthy LC, Hosford DA, Riley HJ. Single nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001; 78:135-149.
14. Cohen GL Migraine prophylactic drugs work via ion channels. Med Hypotheses 2005; 65:14-22.
15. Akerman S, Williamson DJ, Hill RG, Goadsby PJ. The effect of adrenergic compounds on neurogenic durai vasodilatation. Eur J Pharmacol 2001; 424:53-58.
16. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 1988; 8:83-91.
17. Cutrer FM, Limmroth V, Ayata G, Moskowitz MA. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 1995; 116:3199-3204.
18. Akerman S, Goadsby PJ. Topiramate inhibits trigeminovascular activation: an intravital microscopy study. Br J Pharmacol 2005; 146:7-14.
19. Diener HC, Tfelt-Hansen P, Dahlof C, et al. Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004; 251:943-950.
20. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain 2005; 128:86-97.
21. Richter F, Mikulik O, Ebersberger A, Schaible HG. Nadrenergic agonists and antagonists influence migration of cortical spreading depression in rat - a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage. J Cereb Blood Flow Metab 2005; 25:1225-1235.
22. Akerman S, Goadsby PJ. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 2005; 16:1383-1387.
23. Bradley DP, Smith MI, Netsiri C, et al. Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Exp Neurol 2001; 172:342-353.
24. Ayata C, Jin H, Judo C, et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006; [Epub ahead of print]. This is the first study which convincingly demonstrates the efficacy of several powerful prophylactic anti-migraine drugs to suppress the induction of CSD in a dose and time-dependent mode. The study thereby offers a mechanism by which preventive drugs reduce the frequency of migraine attacks.
25. Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001; 98:4687-4692.
26. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128:2068-2077.
27. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427-434.
28. Harno H, Hirvonen T, Kaunisto MA, et al. Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology 2003; 61:1748-1752.
29. Crawford JS, Konkol PJ. Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement. Headache 1997; 37:590-593.
30. +-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 2004; 5:177-185.
31. Dichgans M, Herzog J, Freilinger T, et al. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology 2005; 64:608-613.
32. Ebner TJ, Chen G. Spreading acidification and depression in the cerebellar cortex. Neuroscientist 2003; 9:37-45.
33. Thompson CS, Hakim AM. Cortical spreading depression modifies components of the inflammatory cascade. Mol Neurobiol 2005; 32:51-57.
34. Geraud G, Denuelle M, Fabre N, et al. Positron emission tomographic studies of migraine. Rev Neurol (Paris) 2005; 161:666-670. Imaging study in spontaneous migraine without aura showing simultaneous bilateral cortical hypoperfusion and increased blood flow in subcortical structures.
35. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994; 331:1689-1692.
36. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990; 28:791-798.